If the big pharmas are indeed dinosaurs, they have learned to do what their predecessors could not: survive!
It seems to me that an increasing number of start-ups have been boot-strapping their way through preclinical without venture capital lately.
BioWorld Perspectives is the official blog for news, analysis, debates, commentary and camaraderie related to the development of biotechnology drugs.
Join the Conversation